sellas life sciences group stock
2 months ago - GlobeNewsWire. SELLAS Life Sciences Group Inc.
Pin On Information Is Wealth
SLS SELLAS LIFE SCIENCES GROUPs current Earnings Per Share EPS is -222.
. At the end of the latest market close SELLAS Life Sciences Group Inc. The average SELLAS LIFE SCIENCES GROUP stock price prediction forecasts a potential upside of 31667 from the current SLS share price of 294. TD Securities currently has a speculative buy rating on the stock.
SELLAS Life Sciences Announces Pricing of 250 Million Underwritten Public Offering. The Companys lead product candidate galinpepimut-S GPS is a cancer immunotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center. SELLAS Life Sciences Reports Encouraging Updated Clinical Data Indicating Increased Survival from Ongoing Phase 1 Mesothelioma Study of Galinpepimut-S Combined with Opdivo.
Get Sellas Life Sciences Group Inc SLSNASDAQ real-time stock quotes news price and financial information from CNBC. During the day the stock fluctuated 2791 from a day low at 215 to a day high of 275. SELLAS Life Sciences Groups stock was trading at 553 on January 1st 2022.
The Company is focused on developing cancer immunotherapeutics for a range of cancer indications. SELLAS Life Sciences Group traded as high as C1521 and last traded at Read more. -013 -456 CLOSED AT 400 PM ET ON Apr 29 2022.
SLS 234 013 526 Post-Market 035 1496 41902. SELLAS Life Sciences Group Inc TSESLSs stock price reached a new 52-week high during trading on Thursday after TD Securities raised their price target on the stock from C2100 to C2200. Kura Oncology has a consensus price target of 3800 suggesting a potential.
Learn about SELLAS Life Sciences Group Inc SLSXNAS stock quote with Morningstars rating and analysis and stay up to date with the current news price valuation dividends and other stock. The price has been going up and down for this period and there has been a -2297 loss for the last 2 weeks. Its lead product candidate GPS is a cancer immunotherapeutic agent licensed from.
275 -010. SELLAS Life Sciences Group Inc. SLS SELLAS or the Company a late-stage clinical biopharmaceutical company focused on the development of nov.
16 2022 456 PM ET SELLAS Life Sciences Group Inc. On average analysts forecast that SLSs EPS will. The Score for SLS is 21 which is 58 below its historic median score of 50 and infers higher risk than normal.
Is SELLAS Life Sciences Group Stock Undervalued. What is SLSs Earnings Per Share EPS forecast for 2022-2023. Maxim Group Thinks SELLAS Life Sciences Groups Stock is Going to Recover 06092022 095518 AM SLS News.
SELLAS Life Sciences Group Inc NASDAQ Updated Jun 16 2022 958 PM. The current SELLAS Life Sciences Group share price is 234. Investors Who Bought Sellas Life Sciences Group Nasdaq Sls Shares A Year Ago Are Now Down 97.
And has now fallen 4 days in a row. SELLAS Life Sciences Group Inc. Stock news by MarketWatch.
Shareholders Are Raving About How The Sellas Life Sciences Group Nasdaq Sls Share Price Increased 349. About SELLAS Life Sciences Group. SELLAS Life Sciences Group currently has a consensus price target of 1725 suggesting a potential upside of 65658.
Is a late-stage clinical biopharmaceutical company focused on the development of novel cancer immunotherapies for a broad range of cancer indications. View real-time stock prices and stock quotes for a full financial overview. The SELLAS Life Sciences Group Inc.
1 day agoStock Ideas. Is a clinical-stage biopharmaceutical company. SELLAS Life Sciences Group Inc Registered Shs Stock SLS 296 000 000 Official Close 5272022 NAS.
Stock price fell by -2000 on the last day Monday 13th Jun 2022 from 285 to 228. SLS SELLAS Life Sciences Group IncStock Price Overview. SELLAS Life Sciences Group Inc.
Common Stock SLS Nasdaq Listed. SLS Complete SELLAS Life Sciences Group Inc. About SELLAS Life Sciences Group.
Is a late-stage clinical biopharmaceutical company focused on the development of novel cancer immunotherapies for a broad range of cancer indications. 285 -008 -273 359 PM 061022. SLS SELLAS Life Sciences Group Inc Stock Price and Discussion Stocktwits.
SLS was valued at 285. The Companys product candidates include galinpepimut-S GPS and nelipepimut-S NPS. The average twelve-month price prediction for SELLAS Life Sciences Group is 1725 with a high price target of 2100 and a low price target of 1400.
The stock current value is 228Recently in New. Since then SLS shares have decreased by 463 and is now trading at 297. According to the issued ratings of 3 analysts in the last year the consensus rating for SELLAS Life Sciences Group stock is Buy based on the current 3 buy ratings for SLS.
SLS is currently trading in the 20-30 percentile range relative to its historical Stock Score levels. SELLAS Life Sciences Group SLS Investor Presentation - Slideshow. NEW YORK March 31 2022 GLOBE NEWSWIRE -- SELLAS Life Sciences Group Inc.
View the best growth stocks for 2022 here. The Companys lead product candidate galinpepimut-S GPS is a cancer immunotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center. In that particular session Stock kicked-off at the price of 275 while reaching the peak value of 275 and lowest value recorded on the day was 215.
Client Name Sellas Life Sciences Url Www Sellaslifesciences Com Industry Biopharmaceuticals Site Type Corporate Design Type Life Science Science Life
Client Name Sellas Life Sciences Url Www Sellaslifesciences Com Industry Biopharmaceuticals Site Type Corporate Design Type Life Science Science Life